MEPDPS - 4th Middle East Pharmacoeconomics and Drug Policy Summit 2024

Start

Fri, 23 Feb 2024, 09:00

End

Sat, 24 Feb 2024, 17:00

WebSite

https://iii.hm/mepdps2024

Venue:

Exhibit

Symposia

Workshops

Organiser

Sponsor

OVERVIEW

As healthcare systems evolve, Pharmacoeconomics will remain a key discipline for guiding decisions that optimize outcomes, resource allocation, and the overall sustainability of healthcare.

This Summit has been meticulously crafted to serve as a dynamic platform for thought leaders, policymakers, and key stakeholders to exchange insights, share experiences, in the areas focused on healthcare policy, the HEOR in healthcare decision making, economic evaluations, VBHC, the implications of HTA, responses to Real-World Evidence, collaboration, affordability, and equity in healthcare, that enhance patient outcomes, ensure accessibility to innovative therapies, and contribute to the sustainability of our healthcare infrastructure.

WHO SHOULD ATTEND

Regulatory authorities
Pharmacoeconomists
Health Economists
Health Technology Assessment Specialists
Payers
Healthcare providers
Pharma industry
Pharmacists and more

KEY BENEFITS OF ATTENDING

Highlight future opportunities and challenges in developing the healthcare and research economy in the GCC countries
Discuss the novel approaches to value assessment, achieving cost effective healthcare solutions and access to innovative medicines in the GCC
Understanding the principles of outcome based healthcare and evidence based medication
Reviewing pharmacoeconomics and outcomes research strategies
Exploring the real world data, the burden of disease and HTA to make proper assessments and support decision making